Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

NIP-565: a JAK-1 inhibitor for rheumatoid arthritis

Nov. 16, 2015

Horizon Pharma partners with ALR to study Rayos delayed-release tablets for SLE

Nov. 13, 2015

GKT-137831 receives orphan drug designation in the E.U. for systemic sclerosis

Nov. 11, 2015

Fera Pharmaceuticals licenses U.S. rights to NicOx's naproxcinod

Nov. 10, 2015

Cel-Sci's RA vaccine selected for NIH commercialization and niche analysis plan

Nov. 9, 2015

Viking Therapeutics begins trial of VK-5211 in patients recovering from hip fracture

Nov. 6, 2015

Health Canada approves Cingal for osteoarthritis knee pain

Nov. 5, 2015

Jiangsu Hengrui Medicine patents mPGES-1 inhibitors

Nov. 4, 2015

FDA grants deflazacort orphan drug designation for pediatric juvenile idiopathic arthritis

Oct. 27, 2015

TRPV1 and TRPA1 activation reduces muscular cramps

Oct. 27, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...